GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bcworldpharm Co Ltd (XKRX:200780) » Definitions » Capex-to-Revenue

Bcworldpharm Co (XKRX:200780) Capex-to-Revenue : 0.03 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bcworldpharm Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Bcworldpharm Co's Capital Expenditure for the three months ended in Sep. 2024 was ₩-525.30 Mil. Its Revenue for the three months ended in Sep. 2024 was ₩17,523.87 Mil.

Hence, Bcworldpharm Co's Capex-to-Revenue for the three months ended in Sep. 2024 was 0.03.


Bcworldpharm Co Capex-to-Revenue Historical Data

The historical data trend for Bcworldpharm Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bcworldpharm Co Capex-to-Revenue Chart

Bcworldpharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.15 0.30 0.09 0.04

Bcworldpharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.03 0.04 0.05 0.03

Competitive Comparison of Bcworldpharm Co's Capex-to-Revenue

For the Drug Manufacturers - General subindustry, Bcworldpharm Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bcworldpharm Co's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bcworldpharm Co's Capex-to-Revenue falls into.



Bcworldpharm Co Capex-to-Revenue Calculation

Bcworldpharm Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2708.948) / 75110.699
=0.04

Bcworldpharm Co's Capex-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-525.301) / 17523.865
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bcworldpharm Co  (XKRX:200780) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Bcworldpharm Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bcworldpharm Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bcworldpharm Co Business Description

Traded in Other Exchanges
N/A
Address
78, Gaepo-ro 22-gil, Gangnam-gu, Seoul, KOR
Bcworldpharm Co Ltd is a pharmaceutical company. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics. The products are offered under ALIMA Inj, AROXOL Tab, ASCORBIC Inj and BC CITICOLINE Inj brands.

Bcworldpharm Co Headlines

No Headlines